|
|
||||||||
AJP - Renal Physiology, Vol 259, Issue 6 924-F928, Copyright © 1990 by American Physiological Society
ARTICLES |
A. Bertorello and A. Aperia
Department of Pediatrics, St. Goran's Children's Hospital, Karolinska Institute, Stockholm, Sweden.
This study examines the receptor mechanisms by which dopamine (DA) inhibits Na(+)-K(+)-adenosinetriphosphatase (ATPase) activity in single permeabilized proximal tubule (PCT). Na(+)-K(+)-ATPase activity was inhibited in the presence of both DA1- and DA2-specific agonists but not by either agonist alone. The inhibition induced by DA (10(-6) M) was attenuated in the presence of either of the two DA2-specific antagonists S-sulpiride and YM 09151 at 10(-5) M and in the presence of the DA1 antagonist SCH 23390 (10(-5) M). PCT adenosine 3',5'-cyclic monophosphate (cAMP) levels were significantly increased in the presence of DA and DA1 agonist, but DA2 agonist had no effect on cell cAMP levels. Na(+)-K(+)-ATPase activity was significantly inhibited in PCT incubated with DA2 agonist (10(-5) M) and dibutyryl (DB)-cAMP (10(-6) M) but not with DA2 agonist (10(-5) M) only. PCT Na(+)-K(+)-ATPase activity was also significantly inhibited in the presence of both DA2 agonist (10(-5) M) and forskolin (10(-6) M). Neither DBcAMP (10(-6) M) nor forskolin (10(-6) M) alone inhibited Na(+)-K(+)-ATPase activity. In tubules incubated with DA (10(-8) to 10(-9) M), the presence of DBcAMP (10(-6) M) enhanced the sensitivity by which DA inhibited Na(+)-K(+)-ATPase activity. We conclude that PCT Na(+)-K(+)-ATPase activity is inhibited by a synergistic action of the DA1 and DA2 receptors, with the DA1 receptor acting to increase cell cAMP levels.
This article has been cited by other articles:
![]() |
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kirchheimer, C. F. Mendez, A. Acquier, and S. Nowicki Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1435 - F1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cui, W. L. Dean, and N. A. Delamere The Influence of Cycloheximide on Na,K-ATPase Activity in Cultured Human Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2714 - 2720. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomes and P. Soares-da-Silva D2-like receptor-mediated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels Am J Physiol Renal Physiol, July 1, 2002; 283(1): F114 - F123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Murphy, C. Murray, and G. D. Shorten Fenoldopam -- A Selective Peripheral Dopamine-Receptor Agonist for the Treatment of Severe Hypertension N. Engl. J. Med., November 22, 2001; 345(21): 1548 - 1557. [Full Text] [PDF] |
||||
![]() |
C. A. Ladines, C. Zeng, L. D. Asico, X. Sun, F. Pocchiari, C. Semeraro, J. Pisegna, S. Wank, I. Yamaguchi, G. M. Eisner, et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1071 - R1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure Hypertension, September 1, 2001; 38(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guerrero, E. Lecuona, L. Pesce, K. M. Ridge, and J. I. Sznajder Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L79 - L85. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomes, M. A. Vieira-Coelho, and P. Soares-da-Silva Ouabain-insensitive acidification by dopamine in renal OK cells: primary control of the Na+/H+ exchanger Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R10 - R18. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Li, J. Xu, S. Zheng, F. E. Albrecht, J. E. Robillard, G. M. Eisner, and P. A. Jose D1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1650 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Sweadner and M. S. Feschenko Predicted location and limited accessibility of protein kinase A phosphorylation site on Na-K-ATPase Am J Physiol Cell Physiol, April 1, 2001; 280(4): C1017 - C1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Therien and R. Blostein Mechanisms of sodium pump regulation Am J Physiol Cell Physiol, September 1, 2000; 279(3): C541 - C566. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Thomas, B. Tomlinson, and J. A. J. H. Critchley Modulation of Blood Pressure and Obesity With the Dopamine D2 Receptor Gene TaqI Polymorphism Hypertension, August 1, 2000; 36(2): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quigley, M. Baum, K. M. Reddy, J. C. Griener, and J. R. Falck Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport Am J Physiol Renal Physiol, June 1, 2000; 278(6): F949 - F953. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Yao, X. X. Li, P.-Y. Yu, J. Xu, L. D. Asico, and P. A. Jose Dopamine D1 Receptor and Protein Kinase C Isoforms in Spontaneously Hypertensive Rats Hypertension, December 1, 1998; 32(6): 1049 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain, R. Abdul-Wahab, D. K. Kotak, and M. F. Lokhandwala Bromocriptine Regulates Angiotensin II Response on Sodium Pump in Proximal Tubules Hypertension, December 1, 1998; 32(6): 1054 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. O'Connell, C. J. Vaughan, A. M. Aherne, S. J. Botkin, Z.-Q. Wang, R. A. Felder, and R. M. Carey Expression of the Dopamine D3 Receptor Protein in the Rat Kidney Hypertension, November 1, 1998; 32(5): 886 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Jose, L. D. Asico, G. M. Eisner, F. Pocchiari, C. Semeraro, and R. A. Felder Effects of costimulation of dopamine D1- and D2-like receptors on renal function Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R986 - R994. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hussain and M. F. Lokhandwala Renal Dopamine Receptor Function in Hypertension Hypertension, August 1, 1998; 32(2): 187 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Holtback, Y. Ohtomo, P. Forberg, B. Sahlgren, and A. Aperia Neuropeptide Y shifts equilibrium between alpha - and beta -adrenergic tonus in proximal tubule cells Am J Physiol Renal Physiol, July 1, 1998; 275(1): F1 - F7. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Chibalin, J. R. Zierath, A. I. Katz, P.-O. Berggren, and A. M. Bertorello Phosphatidylinositol 3-Kinase-mediated Endocytosis of Renal Na+,K+-ATPase alpha Subunit in Response to Dopamine Mol. Biol. Cell, May 1, 1998; 9(5): 1209 - 1220. [Abstract] [Full Text] |
||||
![]() |
A. V. Chibalin, C. H. Pedemonte, A. I. Katz, E. Feraille, P.-O. Berggren, and A. M. Bertorello Phosphorylation of the Catalyic alpha -Subunit Constitutes a Triggering Signal for Na+,K+-ATPase Endocytosis J. Biol. Chem., April 10, 1998; 273(15): 8814 - 8819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Cheng, J.-O. Hoog, A. C. Nairn, P. Greengard, and A. Aperia Regulation of rat Na+-K+-ATPase activity by PKC is modulated by state of phosphorylation of Ser-943 by PKA Am J Physiol Cell Physiol, December 1, 1997; 273(6): C1981 - C1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Chibalin, A. I. Katz, P.-O. Berggren, and A. M. Bertorello Receptor-mediated inhibition of renal Na+-K+-ATPase is associated with endocytosis of its alpha - and beta -subunits Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1458 - C1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Feschenko, E. Stevenson, and K. J. Sweadner Interaction of Protein Kinase C and cAMP-dependent Pathways in the Phosphorylation of the Na,K-ATPase J. Biol. Chem., October 27, 2000; 275(44): 34693 - 34700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Hu, L. Fan, L. A. Crowder, Z. Karim-Jimenez, H. Murer, and O. W. Moe Dopamine Acutely Stimulates Na+/H+ Exchanger (NHE3) Endocytosis via Clathrin-coated Vesicles. DEPENDENCE ON PROTEIN KINASE A-MEDIATED NHE3 PHOSPHORYLATION J. Biol. Chem., July 13, 2001; 276(29): 26906 - 26915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomes and P. Soares-da-Silva Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na+-K+-ATPase activity Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1084 - F1096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |